Rigel Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$46.64

+0.79 (+1.72%)

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 73%

Hold 3 27%

Sell 0 0%

Price Target

Analyst Price Target +16.0% upside

Low Target $39.68

Average Target $54.10

High Target $74.39

Current Price $46.64

Current
$46.64

Target
$54.10

$39.68 $54.10 avg $74.39

Scenario Analysis

Bear Case

$39.68

-14.9%

Low target

Base Case

$54.10

+16.0%

Avg target

Bull Case

$74.39

+59.5%

High target

Risk/Reward

4.0x

Highly favorable

Price in Context

52-Week High

$52.24

-10.7% from high

52-Week Low

$24.95

+86.9% from low

Target vs 52W High

$54.10

+3.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%